U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907406) titled 'Comparison Between Efficacy of Gabapentin and Carbamazepine in Neuropathic Pain of Guillain-Barre Syndrome Patients' on Oct. 25.
Brief Summary: This randomized controlled trial compared gabapentin with carbamazepine for the treatment of nerve-related pain in patients with Guillain-Barre syndrome who received plasma exchange. The study tested the hypothesis that pain scores after seven days of treatment differed between the two groups.
The study was conducted at Medical Unit III, Lahore General Hospital, Lahore, and included 60 patients of either sex aged 16-65 years. Patients were randomly assigned by a lottery method to two equal ...